Skip to main content

Advertisement

Log in

Risk-reducing mastectomy: a case series of 124 procedures in Brazilian patients

  • Clinical trial
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Purpose

Women with mutations in breast cancer predisposition genes have a significantly higher lifetime risk of developing breast cancer and can opt for risk-reducing mastectomy. Women with positive family history of cancer can also opt for prophylactic surgery as a preventive method in selected cases. Current studies showed reduced risk of developing breast cancer after prophylactic nipple-sparing mastectomy, however, despite the good clinical outcomes, one of the main concerns regarding nipple-sparing mastectomy (NSM) is the oncological safety of nipple-areola complex preservation. In this study, we aimed to evaluate the indications, complication rates, and unfavorable events of 62 Brazilian patients that underwent risk-reducing NSM from 2004 to 2018.

Methods

Patient data were reviewed retrospectively and descriptive statistics were utilized to summarize the findings.

Results

The mean patients age was 43.8 years. The main indication for risk-reducing NSM was the presence of pathogenic mutation (53.3%), followed by atypia or lobular carcinoma in situ (25.8), and family history of breast cancer and/or ovarian cancer (20.9%). There were four (3.2%) incidental diagnosis of ductal carcinoma in situ and one invasive ductal carcinoma (0.8%). From the 124 prophylactic NSM performed, two (1.6%) complications had occurred: one (0.8%) infection and one (0.8%) partial nipple necrosis. In a mean follow-up of 50 months, there was one (1.6%) newly diagnosed breast cancer in the 62 patients undergoing prophylactic NSM.

Conclusions

Our findings demonstrated efficacy and safety to perform NSM as prophylactic surgery with good oncological outcomes and low complication rates in a case series of Brazilian patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

All data analyzed during this study are included in this published article.

References

  1. Narod SA (2010) BRCA mutations in the management of breast cancer: the state of the art. Nat Rev Clin Oncol 7(12):702–707. https://doi.org/10.1038/nrclinonc.2010.166

    Article  PubMed  CAS  Google Scholar 

  2. Castera L, Krieger S, Rousselin A et al (2014) Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes. Eur J Hum Genet 22:1305–1313. https://doi.org/10.1038/ejhg.2014.16

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Kuchenbaecker KB, Hopper JL, Barnes DR et al (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317(23):2402–2416. https://doi.org/10.1001/jama.2017.7112

    Article  PubMed  CAS  Google Scholar 

  4. Dull B, Conant L, Myckatyn T et al (2017) Nipple-sparing mastectomies: Clinical outcomes from a single academic institution. Mol Clin Oncol 6:737–742. https://doi.org/10.3892/mco.2017.1208

    Article  PubMed  PubMed Central  Google Scholar 

  5. Smith BL, Tang R, Rai U et al (2017) Oncologic safety of nipple-sparing mastectomy in women with breast cancer. J Am Coll Surg 225(3):361–365. https://doi.org/10.1016/j.jamcollsurg.2017.06.013

    Article  PubMed  Google Scholar 

  6. Liede A, Cai M, Crouter TF et al (2018) Risk-reducing mastectomy rates in the US: a closer examination of the Angelina Jolie effect. Breast Cancer Res Treat 171(2):435–442. https://doi.org/10.1007/s10549-018-4824-9

    Article  PubMed  PubMed Central  Google Scholar 

  7. Isaksson K, Arver B, Bottai M et al (2019) Bilateral risk-reducing mastectomies with implant-based reconstructions followed long term: a consecutive series of 185 patients. World J Surg 43:2262–2270. https://doi.org/10.1007/s00268-019-05037-4

    Article  PubMed  Google Scholar 

  8. Manning AT, Wood C, Eaton A et al (2015) Nipple-sparing mastectomy in patients with BRCA1/2 mutations and variants of uncertain significance. Br J Surg 102(11):1354–1359. https://doi.org/10.1002/bjs.9884

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Tondu T, Thiessen F, Tjalma WA (2016) Prophylatic bilateral Nipple-sparing mastectomy ans a staged breast reconstruction technique: preliminar results. Breast Cancer 10:185–189. https://doi.org/10.4137/BCBCR.S40033

    Article  PubMed  Google Scholar 

  10. Muller T, Baratte A, Bruant-Rodier C et al (2018) Oncological safety of nipple-sparing prophylactic mastectomy: a review of the literature on 3716 cases. Ann Chir Plast Esthet 63(3):e6–e13. https://doi.org/10.1016/j.anplas.2017.09.005

    Article  PubMed  CAS  Google Scholar 

  11. Jakub JW, Peled AW, Gray RJ et al (2018) Oncologic safety of prophylactic nipple-sparing mastectomy in a population with BRCA mutations: a multi-institutional study. JAMA 153(2):123–129. https://doi.org/10.1001/jamasurg.2017.3422

    Article  Google Scholar 

  12. Muller T, Baratte A, Bruant-Roider C et al (2018) Oncological safety of nipple-sparing prophylactic mastectomy: a review of the literature on 3716 cases. Ann Chir Plast Esthet 63(3):e6–e13. https://doi.org/10.1016/j.anplas.2017.09.005

    Article  PubMed  CAS  Google Scholar 

  13. Grobmyer SR, Pederson HJ, Valente SA (2018) Evolving indications and long-term oncological outcomes of risk-reducing bilateral nipple-sparing mastectomy. BJS Open 3(2):169–173. https://doi.org/10.1002/bjs5.50117

    Article  PubMed  PubMed Central  Google Scholar 

  14. Wu ZY, Kim HJ, Lee JW et al (2019) Breast cancer recurrence in the nipple-areola complex after nipple-sparing mastectomy with immediate breast reconstruction for invasive breast cancer. JAMA Surg. https://doi.org/10.1001/jamasurg.2019.2959

    Article  PubMed  PubMed Central  Google Scholar 

  15. Eisemann BS, Spiegel AJ (2018) Mastectomy and breast reconstruction: indications and evidence for current management strategies. Clin Plast Surg 45:129–136. https://doi.org/10.1016/j.cps.2017.08.013

    Article  PubMed  Google Scholar 

  16. Henry DA, Lee MC, Almanza D et al (2019) Trends in use of bilateral prophylactic mastectomy vs high-risk surveillance in unaffected carriers of inherited breast cancer syndromes in the Inherited Cancer Registry (ICARE). Breast Cancer Res Treat 174(1):39–45. https://doi.org/10.1007/s10549-018-5057

    Article  PubMed  CAS  Google Scholar 

  17. Beitsch PD, Whitworth PW, Hughes K et al (2019) Underdiagnosis of hereditary breast cancer: are genetic testing guidelines a tool or an obstacle? J Clin Oncol 37(6):453–460. https://doi.org/10.1200/JCO.18.01631

    Article  PubMed  Google Scholar 

  18. Graffeo R, Livraghi L, Pagani O et al (2016) Time too incorporate germline multigene panel testing into breast and ovarian cancer patient care. Breast Cancer Res Treat 160(3):393–410. https://doi.org/10.1007/s10549-016-4003-9

    Article  PubMed  CAS  Google Scholar 

  19. Henry DA, Lee MC, Almanza D et al (2019) Trends in use of bilateral prophylactic mastectomy vs high-risk surveillance in unaffected carriers of inherited breast cancer syndroms in the Inherited Cancer Registry (ICARE). Breast Cancer Res Treat 174(1):39–45. https://doi.org/10.1007/s10549-018-5057-7

    Article  PubMed  CAS  Google Scholar 

  20. Mau C, Untch M (2017) Prophylactic surgey: for whom, when and how? Breast Care 12(6):379–384. https://doi.org/10.1159/000485830

    Article  PubMed  PubMed Central  Google Scholar 

  21. Nelson HD, Pappas M, Cantor A et al (2019) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: Update evidence reports and systemic review for the US preventive services task force. JAMA. 332(7):666–685. https://doi.org/10.1001/jama.2019.8430

    Article  Google Scholar 

  22. Hermel DJ, Wood ME, Chun J et al (2017) Multi-institutional evaluation of women at high risk of developing breast cancer. Clin Breast Cancer 17(6):427–432. https://doi.org/10.1016/j.clbc.2017.04.005

    Article  PubMed  Google Scholar 

  23. Gilbert E, Zabor EC, Stempel M et al (2017) Differences among a modern cohort of BRCA mutation carriers choosing bilateral prophylactic mastectomies compared to breast surveillance. Am Surg Oncol 24:3048–3054. https://doi.org/10.1245/s10434-017-5976-2

    Article  Google Scholar 

  24. De Felice F, Marchetti C, Musella A et al (2015) Bilateral risk-reduction mastectomy in BRCA1 and BRCA2 mutation carriers: a meta-analysis. Ann Surg Oncol 22:2876–2880. https://doi.org/10.1245/s10434-015-4532-1

    Article  PubMed  Google Scholar 

  25. Yao K, Liederbach E, Tang R et al (2015) Nipple-sparing mastectomy in BRCA1/2 mutation carriers: an interim analysis and review of the literature. Ann Surg Oncol 22:370–376. https://doi.org/10.1245/s10434-014-3883-3

    Article  PubMed  Google Scholar 

  26. Lai HW, Chen ST, Tai CM et al (2020) Robotic- versus Endoscopic-assisted nipple-sparing mastectomy with immediate prosthesis breast reconstruction in the management of breast cancer: a case-control comparison study with analysis of clinical outcomes, learning curve, patient-reported aesthetic results, and medical cost. Ann Surg Oncol. https://doi.org/10.1245/s10434-020-08223-0

    Article  PubMed  Google Scholar 

  27. Lai HW, Toesca A, Sarfari B et al (2020) Consensus statement on robotic mastectomy-expert panel from international endoscopic and robotic breast surgery symposium (IERBS) 2019. Ann Surg. https://doi.org/10.1097/SLA.0000000000003789

    Article  PubMed  Google Scholar 

  28. Sarfari B, Leymarie N, Honart JF et al (2018) Robotic prophylactic nipple-sparing mastectomy with immediate prosthetic breast reconstruction: a prospective study. Ann Surg Oncol 25(9):2579–2586. https://doi.org/10.1245/s10434-018-6555-x

    Article  Google Scholar 

  29. Houvenaeghel G, Marie B, Rua S et al (2019) Robotic breast and reconstructive surgery: 100 procedures in 2-years for 80 patients. Surg Oncol 31:38–45. https://doi.org/10.1016/j.suronc.2019.09.005

    Article  PubMed  Google Scholar 

  30. Maruccia M, Elia R, Gurrado A et al (2020) Skin-reducing mastectomy and pre-pectoral breast reconstruction in large ptotic breasts. Aesth Plast Surg. https://doi.org/10.1007/s00266-020-01616-2

    Article  Google Scholar 

  31. Vidya R, Iqbal FM, Becker H, Zhadan O (2019) World J Plast Surg 8(3):311–315. https://doi.org/10.29252/wjps.8.3.311

    Article  PubMed  PubMed Central  Google Scholar 

  32. Khajuria A, Prokopenko M, Greenfield M et al (2019) A meta-analysis of clinical, patient-reported outcomes and cost of DIEP versus implant-based breast reconstruction. Plast Reconstr Surg Glob Open 7(10):e2486

    Article  Google Scholar 

  33. Wade RG, Razzano S, Sassoon EM et al (2017) Complications in DIEP flap breast reconstruction after mastectomy for breast cancer: a prospective cohort study comparing unilateral versus bilateral reconstructions. Ann Surg Oncol 24(6):1465–1474. https://doi.org/10.1245/s10434-017-5807-5

    Article  PubMed  Google Scholar 

Download references

Funding

The authors disclosure that they have no commercial interest in the subject of study and received no financial or material support for the study.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation and writing the manuscript were performed by ALF, MAMRF, ABF, BV and FB; data collection, analysis and writing the manuscript were perfomed by ML and ABAS. The first draft of the manuscript was written by MLs and all authors commented on previous versions of the manuscript. Supervision was performed by ALF.

Corresponding author

Correspondence to Antônio Luiz Frasson.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in the study were in accordance with the ethical standards by the Institutional Ethics Committee of Pontifical Catholic University of Rio Grande do Sul (PUCRS), Hospital Albert Einstein and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

For this type of study (retrospective study) formal consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Frasson, A.L., Lichtenfels, M., de Souza, A.A.B. et al. Risk-reducing mastectomy: a case series of 124 procedures in Brazilian patients. Breast Cancer Res Treat 181, 69–75 (2020). https://doi.org/10.1007/s10549-020-05582-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-020-05582-w

Keywords

Navigation